STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down

Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.

How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →

Every article behind this summary — 1 article from 1 outlet